Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
3
pubmed:dateCreated
2011-6-2
pubmed:abstractText
Reactivation of cytomegalovirus (CMV) is a major cause of morbidity after allogeneic hematopoietic stem cell transplantation (HSCT). In healthy individuals, virus-specific T cells (CMV-CTL) control the reactivation of latent CMV. The monitoring of virus-epitope-binding CD8(+) T cells using major histocompatibility complex-I-peptide complexes (tetramers) has recently been established, allowing assessment of the reconstitution of CMV-CTL post HSCT.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Jun
pubmed:issn
1399-3062
pubmed:author
pubmed:copyrightInfo
© 2011 John Wiley & Sons A/S.
pubmed:issnType
Electronic
pubmed:volume
13
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
222-36
pubmed:meshHeading
pubmed-meshheading:21585633-Adult, pubmed-meshheading:21585633-CD8-Positive T-Lymphocytes, pubmed-meshheading:21585633-Cohort Studies, pubmed-meshheading:21585633-Cytomegalovirus, pubmed-meshheading:21585633-Cytomegalovirus Infections, pubmed-meshheading:21585633-Female, pubmed-meshheading:21585633-Hematopoietic Stem Cell Transplantation, pubmed-meshheading:21585633-Histocompatibility Antigens Class I, pubmed-meshheading:21585633-Humans, pubmed-meshheading:21585633-Immune Reconstitution Inflammatory Syndrome, pubmed-meshheading:21585633-Male, pubmed-meshheading:21585633-Middle Aged, pubmed-meshheading:21585633-Multiprotein Complexes, pubmed-meshheading:21585633-Peptides, pubmed-meshheading:21585633-Recurrence, pubmed-meshheading:21585633-Risk Factors, pubmed-meshheading:21585633-Transplantation, Homologous, pubmed-meshheading:21585633-Virus Activation
pubmed:year
2011
pubmed:articleTitle
Tetramer monitoring to assess risk factors for recurrent cytomegalovirus reactivation and reconstitution of antiviral immunity post allogeneic hematopoietic stem cell transplantation.
pubmed:affiliation
Department of Hematology, Hemostasis, Oncology and Stem Cell Transplantation, Hannover Medical School, Hannover, Germany.
pubmed:publicationType
Journal Article, Evaluation Studies